YiChang HEC ChangJiang Pharmaceutical Co., Ltd.

SEHK:1558 株式レポート

時価総額:HK$8.2b

YiChang HEC ChangJiang Pharmaceutical 過去の業績

過去 基準チェック /36

YiChang HEC ChangJiang Pharmaceuticalの収益は年間平均-2.1%の割合で減少していますが、 Pharmaceuticals業界の収益は年間 増加しています。収益は年間5.7% 6%割合で 増加しています。 YiChang HEC ChangJiang Pharmaceuticalの自己資本利益率は17.5%であり、純利益率は29.7%です。

主要情報

-2.1%

収益成長率

-1.7%

EPS成長率

Pharmaceuticals 業界の成長5.6%
収益成長率6.0%
株主資本利益率17.5%
ネット・マージン29.7%
前回の決算情報30 Jun 2024

最近の業績更新

YiChang HEC ChangJiang Pharmaceutical (HKG:1558) Strong Profits May Be Masking Some Underlying Issues

Oct 07
YiChang HEC ChangJiang Pharmaceutical (HKG:1558) Strong Profits May Be Masking Some Underlying Issues

Recent updates

YiChang HEC ChangJiang Pharmaceutical (HKG:1558) Strong Profits May Be Masking Some Underlying Issues

Oct 07
YiChang HEC ChangJiang Pharmaceutical (HKG:1558) Strong Profits May Be Masking Some Underlying Issues

Should You Be Adding YiChang HEC ChangJiang Pharmaceutical (HKG:1558) To Your Watchlist Today?

Sep 19
Should You Be Adding YiChang HEC ChangJiang Pharmaceutical (HKG:1558) To Your Watchlist Today?

YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s (HKG:1558) Popularity With Investors Under Threat As Stock Sinks 26%

May 29
YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s (HKG:1558) Popularity With Investors Under Threat As Stock Sinks 26%

Do YiChang HEC ChangJiang Pharmaceutical's (HKG:1558) Earnings Warrant Your Attention?

Apr 23
Do YiChang HEC ChangJiang Pharmaceutical's (HKG:1558) Earnings Warrant Your Attention?

YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s (HKG:1558) P/S Is Still On The Mark Following 33% Share Price Bounce

Mar 01
YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s (HKG:1558) P/S Is Still On The Mark Following 33% Share Price Bounce

Investors Appear Satisfied With YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s (HKG:1558) Prospects As Shares Rocket 33%

Mar 01
Investors Appear Satisfied With YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s (HKG:1558) Prospects As Shares Rocket 33%

YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s (HKG:1558) Business Is Trailing The Industry But Its Shares Aren't

Jan 03
YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s (HKG:1558) Business Is Trailing The Industry But Its Shares Aren't

YiChang HEC ChangJiang Pharmaceutical (HKG:1558) Could Easily Take On More Debt

Sep 25
YiChang HEC ChangJiang Pharmaceutical (HKG:1558) Could Easily Take On More Debt

Does YiChang HEC ChangJiang Pharmaceutical (HKG:1558) Have A Healthy Balance Sheet?

Nov 25
Does YiChang HEC ChangJiang Pharmaceutical (HKG:1558) Have A Healthy Balance Sheet?

Is YiChang HEC ChangJiang Pharmaceutical (HKG:1558) A Risky Investment?

Mar 23
Is YiChang HEC ChangJiang Pharmaceutical (HKG:1558) A Risky Investment?

Does This Valuation Of YiChang HEC ChangJiang Pharmaceutical Co., Ltd. (HKG:1558) Imply Investors Are Overpaying?

Oct 29
Does This Valuation Of YiChang HEC ChangJiang Pharmaceutical Co., Ltd. (HKG:1558) Imply Investors Are Overpaying?

Here's Why YiChang HEC ChangJiang Pharmaceutical (HKG:1558) Has A Meaningful Debt Burden

Apr 13
Here's Why YiChang HEC ChangJiang Pharmaceutical (HKG:1558) Has A Meaningful Debt Burden

YiChang HEC ChangJiang Pharmaceutical Co., Ltd. (HKG:1558) Analysts Just Cut Their EPS Forecasts Substantially

Mar 23
YiChang HEC ChangJiang Pharmaceutical Co., Ltd. (HKG:1558) Analysts Just Cut Their EPS Forecasts Substantially

YiChang HEC ChangJiang Pharmaceutical's(HKG:1558) Share Price Is Down 55% Over The Past Three Years.

Mar 13
YiChang HEC ChangJiang Pharmaceutical's(HKG:1558) Share Price Is Down 55% Over The Past Three Years.

YiChang HEC ChangJiang Pharmaceutical (HKG:1558) Is Growing Earnings But Are They A Good Guide?

Feb 20
YiChang HEC ChangJiang Pharmaceutical (HKG:1558) Is Growing Earnings But Are They A Good Guide?

Do Institutions Own YiChang HEC ChangJiang Pharmaceutical Co., Ltd. (HKG:1558) Shares?

Feb 02
Do Institutions Own YiChang HEC ChangJiang Pharmaceutical Co., Ltd. (HKG:1558) Shares?

YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s (HKG:1558) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Dec 26
YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s (HKG:1558) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Key Things To Watch Out For If You Are After YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s (HKG:1558) 5.1% Dividend

Dec 13
Key Things To Watch Out For If You Are After YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s (HKG:1558) 5.1% Dividend

What Type Of Returns Would YiChang HEC ChangJiang Pharmaceutical's(HKG:1558) Shareholders Have Earned If They Purchased Their SharesYear Ago?

Nov 30
What Type Of Returns Would YiChang HEC ChangJiang Pharmaceutical's(HKG:1558) Shareholders Have Earned If They Purchased Their SharesYear Ago?

収支内訳

YiChang HEC ChangJiang Pharmaceutical の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。


収益と収入の歴史

SEHK:1558 収益、費用、利益 ( )CNY Millions
日付収益収益G+A経費研究開発費
30 Jun 245,5401,6481,891360
31 Mar 245,9171,8201,915276
31 Dec 236,2951,9931,939192
30 Sep 235,9781,5661,870190
30 Jun 235,6611,1391,801187
31 Mar 234,7036081,676158
31 Dec 223,745771,551130
30 Sep 222,875-181,324115
30 Jun 222,005-1131,097101
31 Mar 221,459-351990105
31 Dec 21914-588883110
30 Sep 21690-43698698
30 Jun 21467-2851,08987
31 Mar 211,4072771,27890
31 Dec 202,3488391,46892
30 Sep 203,7921,2041,93374
30 Jun 205,2361,5682,39955
31 Mar 205,7301,7432,63427
31 Dec 196,2241,9192,8690
30 Sep 195,1621,5982,3560
30 Jun 194,0991,2761,8430
31 Mar 193,3051,1091,4410
31 Dec 182,5109431,0380
30 Sep 182,4669619680
30 Jun 182,4229808970
31 Mar 182,0128137310
31 Dec 171,6026475650
30 Sep 171,3255574430
30 Jun 171,0484673220
31 Mar 179954243180
31 Dec 169423813140
30 Sep 169043542940
30 Jun 168663272740
31 Mar 167792972360
31 Dec 156932661970
30 Sep 156372361900
30 Jun 155812071830
31 Mar 155111711770
31 Dec 144411351700
31 Dec 13316581410

質の高い収益: 1558 非現金収入 のレベルが高いです。

利益率の向上: 1558の現在の純利益率 (29.7%)は、昨年(20.1%)よりも高くなっています。


フリー・キャッシュフローと収益の比較


過去の収益成長分析

収益動向: 1558の収益は過去 5 年間で年間2.1%減少しました。

成長の加速: 1558の過去 1 年間の収益成長率 ( 44.7% ) は、5 年間の平均 ( 年間-2.1%を上回っています。

収益対業界: 1558の過去 1 年間の収益成長率 ( 44.7% ) はPharmaceuticals業界9.4%を上回りました。


株主資本利益率

高いROE: 1558の 自己資本利益率 ( 17.5% ) は 低い とみなされます。


総資産利益率


使用総資本利益率


過去の好業績企業の発掘